Ampio Pharmaceuticals, Inc.
AMPEDrugs in Pipeline
4
Phase 3 Programs
2
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
4 mL injection of AMPION™
Osteoarthritis of the Knee
4 mL injection of Ampion
Osteoarthritis of the Knee
10 mL Injection of Ampion
Osteoarthritis of the Knee
Danazol Capsules
Diabetic Macular Edema
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
4 mL injection of AMPION™ | Phase 3 | Osteoarthritis of the Knee | - | - |
4 mL injection of Ampion | Phase 3 | Osteoarthritis of the Knee | - | - |
10 mL Injection of Ampion | Phase 2 | Osteoarthritis of the Knee | - | - |
Danazol Capsules | Phase 2 | Diabetic Macular Edema | - | - |
Frequently asked questions
What is in Ampio Pharmaceuticals, Inc.'s drug pipeline?→
CatalystAlert tracks 4 drug candidates in Ampio Pharmaceuticals, Inc.'s (AMPE) pipeline across Phase 3, Phase 2. Its lead program is 4 mL injection of AMPION™ (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Ampio Pharmaceuticals, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Ampio Pharmaceuticals, Inc. (AMPE) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track AMPE biotech catalysts?→
Add AMPE to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Ampio Pharmaceuticals, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.